Login to your account

Username *
Password *
Remember Me

RECOVERY Trial: Aspirin as an add-on therapy did not reduce mortality in patients hospitalized with COVID-19.

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Studying the coagulopathy of COVID-19 – The Lancet   Commentary from the author on Twitter (thread – click for more) RECOVERY Publication: ASPIRIN(a widely used anti-platelet treatment in other settings) 14 892 patients hospitalised with COVID-19. […]

The post RECOVERY Trial: Aspirin as an add-on therapy did not reduce mortality in patients hospitalized with COVID-19. appeared first on Links Medicus.

[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.

Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis – medRxiv Commentary: Favourable meta-analysis of inhaled corticosteroids in COVID-19 outpatients – News Medical Related: PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community. Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19. […]

The post [Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients. appeared first on Links Medicus.

Observational study finds the effectiveness of mRNA vaccination against Covid-19 hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%).

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 – CDC Morbidity and Mortality Weekly Report Related: CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.   Commentary on Twitter (thread – click for more) New CDC study of mRNA #vaccination & disease in 89,000 […]

The post Observational study finds the effectiveness of mRNA vaccination against Covid-19 hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%). appeared first on Links Medicus.

M-A: Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality.

Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis – The BMJ   Commentary on Twitter Experts call for continued use of personal protective and social measures alongside covid-19 vaccination in @bmj_latest today https://t.co/MOT4O2R6Ui pic.twitter.com/dAxhStSxpJ — BMJ (@bmj_company) November 18, 2021  

The post M-A: Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality. appeared first on Links Medicus.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians – The Journal of the American Board of Family Medicine Related: Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected […]

The post Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians. appeared first on Links Medicus.

The big questions about Covid-19 booster shots – “From the why to the who, we still need a lot of answers about booster shots”.

The big questions about Covid-19 booster shots – Vox   Commentary on Twitter 1/ Thoughtful piece by @voxdotcom's @germanrlopez on COVID vaccine boosters. In good company with @ashishkjha @DrPaulOffit @MonicaGandhi9 @jenkatesdc.https://t.co/pOwZLkmJHn pic.twitter.com/ZAD7AOj0Vz — Céline Gounder, MD, ScM, FIDSA (@celinegounder) November 12, 2021  

The post The big questions about Covid-19 booster shots – “From the why to the who, we still need a lot of answers about booster shots”. appeared first on Links Medicus.

Case-control study: sleep disorders linked to more severe outcomes from COVID-19, study suggests.

News Release: Sleep disorders linked with more severe outcomes from COVID-19, study suggests – Cleveland Clinic Original Study: Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System – JAMA Network Open Commentary: Some sleep disorders may lead to worse COVID-19 outcomes – CIDRAP   Commentary on Twitter […]

The post Case-control study: sleep disorders linked to more severe outcomes from COVID-19, study suggests. appeared first on Links Medicus.

Observational study found monitoring outpatients with Covid-19 using text messages that allowed the report of worsening symptoms was associated with improved outcomes.

Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home – Annals of Internal Medicine News Release: Automated Texting System Saved Lives Weekly During First COVID Surge – Penn Medicine Commentaries: Monitoring outpatients by text appeared to reduce mortality from COVID-19 – ACP Internist Texting saved lives during Covid. What does that […]

The post Observational study found monitoring outpatients with Covid-19 using text messages that allowed the report of worsening symptoms was associated with improved outcomes. appeared first on Links Medicus.

M-A: Prediction of extubation outcome in critically ill patients.

Prediction of extubation outcome in critically ill patients: a systematic review and meta-analysis – Critical Care  

The post M-A: Prediction of extubation outcome in critically ill patients. appeared first on Links Medicus.

Merck v Pfizer: here’s how the two new COVID antiviral drugs work and will be used.

Merck v Pfizer: here’s how the two new COVID antiviral drugs work and will be used – The Conversation Related: COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”. [Press release – not […]

The post Merck v Pfizer: here’s how the two new COVID antiviral drugs work and will be used. appeared first on Links Medicus.